TipRanks on MSN

Nihon Kohden’s Innovative Heart Failure Study: Market Implications and Progress

Nihon Kohden Corporation (($JP:6849)) announced an update on their ongoing clinical study. Study Overview: Nihon Kohden Corporation is conducting ...
TipRanks on MSN

Nihon Kohden’s Innovative Approach to Hemodynamic Measurement: A Game Changer?

Nihon Kohden Corporation (($JP:6849)) announced an update on their ongoing clinical study. The recent clinical study update from Nihon Kohden ...
Becker's Hospital Review

AHRQ Releases New Event-Specific Common Formats For Venous Thromboembolism and Device or Medical/Surgical Supply

The Agency for Healthcare Research and Quality has released Common Formats – Hospital Version 1.2 which incorporates the event-specific formats entitled “Venous Thromboembolism” and “Device or Medical ...
ascopubs.org

Registro central venous devices (CVD) - Polonord

Efficacy and safety of ultrasound-guided central venous access in oncological and haematological patients: Results of a monocenter series of 519 consecutive patients No significant financial ...
La Grande Observer

New Study Demonstrates Potential for Enhanced Accuracy of Blood Cultures with Steripath® Initial Specimen Diversion Device® (ISDD®) for Central Line Draws

SEATTLE, March 5, 2025 /PRNewswire/ — Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device ® (ISDD ®) technology, today announced groundbreaking new findings from an ...
ascopubs.org

Safe and Cost Effective Use of Alteplase for the Clearance of Occluded Central Venous Access Devices

Phase I and Pharmacologic Study of Oral ZD9331, A Novel Nonpolyglutamated Thymidylate Synthase Inhibitor, in Adult Patients With Solid Tumors PURPOSE: To determine whether cryopreserved solutions of ...